Search | IOVS | ARVO Journals

Showing 1 – 20 of 23

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

Special Issue September 2017

Correlation Between Macular Integrity Assessment and Optical Coherence Tomography Imaging of Ellipsoid Zone in Macular Telangiectasia Type 2

PDF

Dibyendu Mukherjee; Eleonora M. Lad; Ryan R. Vann; Stephanie J. Jaffe; Traci E. Clemons; Martin Friedlander; Emily Y. Chew; Glenn J. Jaffe; Sina Farsiu; for the MacTel Study Group
TAGS: diagnostic imaging, eye, optical coherence tomography, personal integrity, telangiectasis, spectral domain-optical coherence tomography
Invest. Ophthalmol. Vis. Sci.. 2017; 58(6):BIO291-BIO299. doi: https://doi.org/10.1167/iovs.17-21834

ARVO Annual Meeting Abstract June 2015

Responsiveness and the minimal clinically important difference for the NEI VFQ-25 in patients with Macular Telangectasia Type 2 (MacTel Type 2)

Traci E Clemons; Emily Y Chew; Tunde Peto; Ferenc Sallo; MacTel Study Group

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):1360. doi:

ARVO Annual Meeting Abstract June 2015

36-months follow-up of the Phase 1 clinical trial of the use ciliary neurotrophic factor (CNTF) for Macular Telangiectasia Type 2 (MacTel)

Tunde Peto; Traci E Clemons; Emily Y Chew; Irene Leung; Ferenc Sallo; Alan C Bird; MacTel Study Group

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):1815. doi:

ARVO Annual Meeting Abstract June 2015

Three-dimensional characteristics of outer retinal atrophy in type 2 idiopathic macular telangiectasia.

Ferenc B Sallo; Irene Leung; Vincent Rocco; Meike Zeimer; Britta Heimes; Traci E Clemons; Daniel Pauleikhoff; Emily Y Chew; Alan C Bird; Tunde Peto; MacTel Study Group.

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):2783. doi:

ARVO Annual Meeting Abstract April 2014

Progression of Inner Segment/Outer Segment junction breaks in Macular Telangectasia type 2 and association with change in visual acuity over a period of 5 years

Konstantinos Balaskas; Ferenc B Sallo; Irene leung; Traci E Clemons; Emily Y Chew; Alan C Bird; Tunde Peto; MacTel Study Group

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):4573. doi:

ARVO Annual Meeting Abstract April 2014

Feasibility of microperimetry testing at multiple sites in type 2 idiopathic macular telangiectasia

Stela Vujosevic; Ferenc B Sallo; Irene leung; Daniela Ioana Florea; Daniel Pauleikhoff; Traci E Clemons; Alan C Bird; Tunde Peto; MacTel Study Group

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):5013. doi:

ARVO Annual Meeting Abstract April 2014

Patterns of retinal sensitivity loss in type 2 idiopathic macular telangiectasia (MacTel).

Ferenc B Sallo; Irene Leung; Stela Vujosevic; Traci E Clemons; Alan C Bird; Daniel Pauleikhoff; Tunde Peto; MacTel Study group

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):5948. doi:

ARVO Annual Meeting Abstract April 2014

Characteristics of pigmented lesions in type 2 idiopathic macular telangiectasia (MacTel).

Irene Leung; Ferenc B Sallo; Daniel Pauleikhoff; Alan C Bird; Traci E Clemons; Tunde Peto; MacTel Study group

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):5950. doi:

ARVO Annual Meeting Abstract April 2014

Comparison of two microperimetry tests in a clincial trial for Macular Telangiectasia Type 2

Tunde Peto; Stela Vujosevic; Ferenc B Sallo; Daniela Florea; Irene Leung; Traci E Clemons; Emily Y Chew; Alan C Bird; MacTel Study Group

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):674. doi:

ARVO Annual Meeting Abstract June 2013

Adaptive optics and 'en face' OCT imaging of the outer retina in Type 2 Macular Telangiectasia

Ferenc Sallo; Valerie Krivosic; Kiyoko Gocho; Michel Paques; Tunde Peto; Alan Bird; Alain Gaudric; MacTel Study Group

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):1510. doi:

ARVO Annual Meeting Abstract June 2013

Severity And Progression Of Diabetic Retinopathy In Type 2 Macular Telangiectasia (MacTel)

Simona Degli Esposti; Tunde Peto; Irene Leung; Ferenc Sallo; Catherine Egan; MacTel Study Group

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):1531. doi:

ARVO Annual Meeting Abstract June 2013

Subretinal neovascularisation in Macular Telangiectasia type 2: Baseline characteristics and progression over two years

Konstantinos Balaskas; Ferenc Sallo; Irene Leung; Daniela Florea; Alan Bird; Tunde Peto; MacTel Study Group

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):1563. doi:

ARVO Annual Meeting Abstract June 2013

Comparison of main OCT features of Type 2 macular telangiectasia in time- and spectral domain OCTs

Tunde Peto; Irene Leung; Ferenc Sallo; Daniela Florea; Alan Bird; MacTel Study Group

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):3604. doi:

Retina November 2012

The IS/OS Junction Layer in the Natural History of Type 2 Idiopathic Macular Telangiectasia

PDF

Ferenc B. Sallo; Tunde Peto; Catherine Egan; Ute E. K. Wolf-Schnurrbusch; Traci E. Clemons; Mark C. Gillies; Daniel Pauleikhoff; Gary S. Rubin; Emily Y. Chew; Alan C. Bird; the MacTel Study Group
TAGS: diagnostic imaging, eye, face, natural history, telangiectasis, retina
Invest. Ophthalmol. Vis. Sci.. 2012; 53(12):7889-7895. doi: https://doi.org/10.1167/iovs.12-10765

Retina September 2012

“En face” OCT Imaging of the IS/OS Junction Line in Type 2 Idiopathic Macular Telangiectasia

PDF

Ferenc B. Sallo; Tunde Peto; Catherine Egan; Ute E. K. Wolf-Schnurrbusch; Traci E. Clemons; Mark C. Gillies; Daniel Pauleikhoff; Gary S. Rubin; Emily Y. Chew; Alan C. Bird; the MacTel Study Group10
TAGS: diagnostic imaging, eye, face, telangiectasis
Invest. Ophthalmol. Vis. Sci.. 2012; 53(10):6145-6152. doi: https://doi.org/10.1167/iovs.12-10580

ARVO Annual Meeting Abstract March 2012

Agreement Between Time Domain And Spectral Domain OCT In Assessment Of Macular Thickness In Patients With Macular Telangiectasia Type 2

Raeba Mathew; Irene Leung; Ferenc Sallo; Alan C. Bird; Tunde Peto; MacTel Study Group

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):981. doi:

ARVO Annual Meeting Abstract April 2011

Function And Phenotype In The Natural History Of Type 2 Idiopathic Macular Telangiectasia

Ferenc B. Sallo; Tunde Peto; Emily Y. Chew; Alan C. Bird; Traci E. Clemons; MacTel Study Group

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):4523. doi:

ARVO Annual Meeting Abstract April 2011

Comparison of Different Image Modalities In Patients With Type 2 Macular Telangiectasia

Tunde Peto; Irene Leung; Ferenc Sallo; Alan C. Bird; Daniel Pauleikhoff; MacTel Study Group

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):4526. doi:

ARVO Annual Meeting Abstract April 2011

Hyper-Autofluorescent Drusen-Like Deposits in Type 2 Macular Telangiectasia

Ashraf Gango; Tunde Peto; Imre Lengyel; Daniel Pauleikhoff; Alan C. Bird; MacTel Study Group

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):4528. doi:

ARVO Annual Meeting Abstract April 2010

Retinal Crystals in Type 2 Idiopathic Macular Telangiectasia

F. B. Sallo; I. Leung; U. E. Wolf-Schnurrbusch; A. C. Bird; T. Peto; MacTel Study Group

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):3549. doi:

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Correlation Between Macular Integrity Assessment and Optical Coherence Tomography Imaging of Ellipsoid Zone in Macular Telangiectasia Type 2

Responsiveness and the minimal clinically important difference for the NEI VFQ-25 in patients with Macular Telangectasia Type 2 (MacTel Type 2)

36-months follow-up of the Phase 1 clinical trial of the use ciliary neurotrophic factor (CNTF) for Macular Telangiectasia Type 2 (MacTel)

Three-dimensional characteristics of outer retinal atrophy in type 2 idiopathic macular telangiectasia.

Progression of Inner Segment/Outer Segment junction breaks in Macular Telangectasia type 2 and association with change in visual acuity over a period of 5 years

Feasibility of microperimetry testing at multiple sites in type 2 idiopathic macular telangiectasia

Patterns of retinal sensitivity loss in type 2 idiopathic macular telangiectasia (MacTel).

Characteristics of pigmented lesions in type 2 idiopathic macular telangiectasia (MacTel).

Comparison of two microperimetry tests in a clincial trial for Macular Telangiectasia Type 2

Adaptive optics and 'en face' OCT imaging of the outer retina in Type 2 Macular Telangiectasia

Severity And Progression Of Diabetic Retinopathy In Type 2 Macular Telangiectasia (MacTel)

Subretinal neovascularisation in Macular Telangiectasia type 2: Baseline characteristics and progression over two years

Comparison of main OCT features of Type 2 macular telangiectasia in time- and spectral domain OCTs

The IS/OS Junction Layer in the Natural History of Type 2 Idiopathic Macular Telangiectasia

“En face” OCT Imaging of the IS/OS Junction Line in Type 2 Idiopathic Macular Telangiectasia

Agreement Between Time Domain And Spectral Domain OCT In Assessment Of Macular Thickness In Patients With Macular Telangiectasia Type 2

Function And Phenotype In The Natural History Of Type 2 Idiopathic Macular Telangiectasia

Comparison of Different Image Modalities In Patients With Type 2 Macular Telangiectasia

Hyper-Autofluorescent Drusen-Like Deposits in Type 2 Macular Telangiectasia

Retinal Crystals in Type 2 Idiopathic Macular Telangiectasia

To View More...

You must be signed into an individual account to use this feature.